Q4 EPS Forecast for Quipt Home Medical Raised by Analyst

Quipt Home Medical Corp. (NASDAQ:QIPT) – Analysts at Stifel Canada boosted their Q4 2025 EPS estimates for Quipt Home Medical in a note issued to investors on Tuesday, February 11th. Stifel Canada analyst J. Keywood now anticipates that the company will post earnings per share of $0.03 for the quarter, up from their previous forecast of $0.02. The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share.

Quipt Home Medical Trading Down 1.7 %

QIPT opened at $2.90 on Thursday. The stock has a fifty day moving average of $2.89 and a 200-day moving average of $2.86. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.86 and a current ratio of 1.20. Quipt Home Medical has a 12-month low of $2.30 and a 12-month high of $4.98.

Quipt Home Medical (NASDAQ:QIPT) last issued its quarterly earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Institutional Investors Weigh In On Quipt Home Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in QIPT. Geode Capital Management LLC grew its holdings in shares of Quipt Home Medical by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 512,304 shares of the company’s stock valued at $1,563,000 after acquiring an additional 4,242 shares in the last quarter. Wells Fargo & Company MN grew its stake in Quipt Home Medical by 30.9% in the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock valued at $73,000 after purchasing an additional 5,625 shares in the last quarter. State Street Corp grew its stake in Quipt Home Medical by 1.0% in the third quarter. State Street Corp now owns 621,388 shares of the company’s stock valued at $1,814,000 after purchasing an additional 6,317 shares in the last quarter. Jane Street Group LLC increased its position in Quipt Home Medical by 28.5% in the 3rd quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock worth $122,000 after purchasing an additional 9,290 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Quipt Home Medical by 68.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock valued at $89,000 after buying an additional 12,383 shares during the last quarter. Hedge funds and other institutional investors own 42.85% of the company’s stock.

Insider Activity at Quipt Home Medical

In related news, VP Patrick Dennis Gamble purchased 17,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 26th. The stock was acquired at an average cost of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the acquisition, the vice president now owns 40,057 shares in the company, valued at $98,139.65. This trade represents a 73.73 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.40% of the stock is owned by insiders.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.